entertainment -WSS

entertainment

author：focus 2025-10-01 23:38:46 - browse：41228

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Doctors have an ethical obligation to be advocates

entertainment

WSS

PBM executives asked to testify by House panel

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Severe heat forecast: Where scorching temperatures will persist over the next week

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Malaysia cuts short music fest after British band slams anti

AltruBio raises $225 million to develop ulcerative colitis drug

focus

entertainment

hotspot

Supreme Court strikes down use of affirmative action

Brain MRIs reveal impact of 'toxic stress' on Black children

Medical records are filled with copy

Burning questions about Delta and the next phase of the Covid pandemic

Cancer drug shortages should be causing more outrage

My chronic pain journey would have been easier knowing 5 things % STAT

Virginia high school admissions case could be legal follow

4 missing after record

Hepatitis C has a cure — but many Americans still lack access to it

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

hotspot

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

PrEP can help anyone prevent HIV. Why do so few people take it?

AI for drug discovery: Experts on separating hype from reality

Transgender women dream of pregnancy via uterus transplants

Most antidepressants don't work on kids, teens, study finds

Brain MRIs reveal impact of 'toxic stress' on Black children

entertainment

focus

hotspot

leisure time